REFERENCES
- IMS Health. MIS Drug Monitor. World drug purchases—retail pharmacies. IIVIS Health-Drug Monitor: 12 months to December 2001. www.open.imshealth.com/ download/dec2001.pdf.
- Danzon P, Wang R, Wang L. The impact of price regulation on the launch delay of new drugs—Evidence from twenty-five major markets in the 1990s. NBER Working Paper 9874; 2003.
- Grabowski HG, Vernon JM. The determinants of pharmaceutical research and development expenditures. J Evolutionary Econ. 2000; 10:201–15.
- Vernon J. Drug research and price controls. Regulation. 2002; 25(4):22–25.
- DiMasi J, Hansen RW, Grabowski HG. The price of innovation: New estimates of drug development costs. J Health Econ. 2003; 22:151–85.
- Crooks GM. Personal communication. 2004 Apr 19.